Indication
Leprosy
Leprosy, also referred to as Hansen disease, is a chronic granulomatous infection primarily caused by the obligate intracellular acid-fast bacilli *Mycobacterium leprae* and *Mycobacterium lepromatosis*. Read more about Leprosy
14 drugs 14 manufacturers
Drugs that treat it
Common Leprosy therapies.
DAPSONE
DAPSONE
DAPSONE
LAMPRENE (clofazimine)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLeprosy, also referred to as Hansen disease, is a chronic granulomatous infection primarily caused by the obligate intracellular acid-fast bacilli *Mycobacterium leprae* and *Mycobacterium lepromatosis*.
The infection predominantly targets the peripheral nervous system, skin, upper respiratory tract mucosa, and eyes across susceptible human populations.
Pathophysiologically, the bacteria demonstrate a unique predilection for Schwann cells and dermal macrophages, producing clinical manifestations across an immunological spectrum ranging from tuberculoid to lepromatous disease.
Defining clinical features include hypopigmented or erythematous skin lesions exhibiting sensory impairment, peripheral nerve enlargement with sensory or motor deficits, and, in severe or progressive cases, chronic ulcerations and disabling physical deformities.
- nih.gov
Leprosy, also referred to as Hansen disease, is a chronic granulomatous infection primarily caused by the obligate intracellular acid-fast bacilli *Mycobacterium leprae* and *Mycobacterium lepromatosis* The infection predominantly targets the peripheral nervous system, skin, upper respiratory tract mucosa, and eyes across susceptible human populations
- cdc.gov
Leprosy, also referred to as Hansen disease, is a chronic granulomatous infection primarily caused by the obligate intracellular acid-fast bacilli *Mycobacterium leprae* and *Mycobacterium lepromatosis* Pathophysiologically, the bacteria demonstrate a unique predilection for Schwann cells and dermal macrophages, producing clinical manifestations across an immunological spectrum ranging from tuberculoid to lepromatous disease
- nih.gov
The infection predominantly targets the peripheral nervous system, skin, upper respiratory tract mucosa, and eyes across susceptible human populations
- nih.gov
Pathophysiologically, the bacteria demonstrate a unique predilection for Schwann cells and dermal macrophages, producing clinical manifestations across an immunological spectrum ranging from tuberculoid to lepromatous disease Defining clinical features include hypopigmented or erythematous skin lesions exhibiting sensory impairment, peripheral nerve enlargement with sensory or motor deficits, and, in severe or progressive cases, chronic ulcerations and disabling physical deformities
- who.int
Defining clinical features include hypopigmented or erythematous skin lesions exhibiting sensory impairment, peripheral nerve enlargement with sensory or motor deficits, and, in severe or progressive cases, chronic ulcerations and disabling physical deformities
- medlineplus.gov
Defining clinical features include hypopigmented or erythematous skin lesions exhibiting sensory impairment, peripheral nerve enlargement with sensory or motor deficits, and, in severe or progressive cases, chronic ulcerations and disabling physical deformities
Personalize your experience
Follow Leprosy and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.